UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association

Arteriosclerosis, thrombosis, and vascular biology, 2022-06, Vol.42 (6), p.e168

2022

Volltextzugriff (PDF)

Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile

JAMA : the journal of the American Medical Association, 2013-11, Vol.310 (19), p.2061

2013

Volltextzugriff (PDF)

Friedewald-Estimated Versus Directly Measured Low-Density Lipoprotein Cholesterol and Treatment Implications

Journal of the American College of Cardiology, 2013-08, Vol.62 (8), p.732-739

2013

Volltextzugriff (PDF)

Therapeutic Lipidology

2nd Edition 2021, 2020

Volltextzugriff (PDF)

Management of Statin Intolerance in 2018: Still More Questions Than Answers

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2018-06, Vol.18 (3), p.157-173

2018

Volltextzugriff (PDF)

Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis

Lipids in health and disease, 2019-09, Vol.18 (1), p.175-175, Article 175

2019

Volltextzugriff (PDF)

Inflammation and cardiovascular disease: From mechanisms to therapeutics

American journal of preventive cardiology, 2020-12, Vol.4, p.100130-100130, Article 100130

2020

Volltextzugriff (PDF)

Polyphenols: Potential Use in the Prevention and Treatment of Cardiovascular Diseases

Current pharmaceutical design, 2018-01, Vol.24 (2), p.239-258

2018

Volltextzugriff (PDF)

2023: The year in cardiovascular disease - the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?

Archives of medical science, 2023-01, Vol.19 (6), p.1602-1615

2023

Volltextzugriff (PDF)

Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies

BMC medicine, 2015-09, Vol.13 (1), p.229-229, Article 229

2015

Volltextzugriff (PDF)

Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms

Atherosclerosis, 2016-10, Vol.253, p.194-208

2016

Volltextzugriff (PDF)

Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials

Atherosclerosis, 2015-08, Vol.241 (2), p.433-442

2015

Volltextzugriff (PDF)

High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real-World Administrative Claims Analysis of Statin-Treated Patients With High Residual Cardiovascular Risk

Journal of the American Heart Association, 2018-08, Vol.7 (15), p.e008740-e008740

2018

Volltextzugriff (PDF)

Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study

European heart journal, 2018-10, Vol.39 (40), p.3641-3653

2018

Volltextzugriff (PDF)

Pooled Safety Analysis of Evolocumab in Over 6000 Patients From Double-Blind and Open-Label Extension Studies

Circulation (New York, N.Y.), 2017-05, Vol.135 (19), p.1819-1831

2017

Volltextzugriff (PDF)

Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation

International journal of cardiology, 2014-02, Vol.171 (3), p.309-325

2014

Volltextzugriff (PDF)

Novel Therapeutic Targets for Managing Dyslipidemia

Trends in pharmacological sciences (Regular ed.), 2018-08, Vol.39 (8), p.733-747

2018

Volltextzugriff (PDF)

There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness

American journal of preventive cardiology, 2022-12, Vol.12, p.100371-100371, Article 100371

2022

Volltextzugriff (PDF)

Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin‐associated muscle symptoms, under blinded and open‐label conditions

Journal of cachexia, sarcopenia and muscle, 2018-12, Vol.9 (6), p.1023-1033

2018

Volltextzugriff (PDF)

Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement

American journal of preventive cardiology, 2022-06, Vol.10, p.100335-100335, Article 100335

2022

Volltextzugriff (PDF)

ASPC president's page: Getting back to basics one patient at a time

American journal of preventive cardiology, 2022-06, Vol.10, p.100350-100350, Article 100350

Toth, Peter P.

2022

Volltextzugriff (PDF)

Use of supplemental long-chain omega-3 fatty acids and risk for cardiac death: An updated meta-analysis and review of research gaps

Journal of clinical lipidology, 2017-09, Vol.11 (5), p.1152-1160.e2

2017

Volltextzugriff (PDF)

Lipoprotein Subfractions in Patients with Acute Coronary Syndromes: Should we Reach Beyond LDL-C?

Current vascular pharmacology, 2019-01, Vol.17 (4), p.376-378

Toth, Peter P

2019

Volltextzugriff (PDF)

The Relationship between COVID-19 and Hypothalamic–Pituitary–Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess—The CAPISCO International Expert Panel

International journal of molecular sciences, 2022-07, Vol.23 (13), p.7326

2022

Volltextzugriff (PDF)

President's page: ASPC is leading the way in preventive cardiology

American journal of preventive cardiology, 2022-03, Vol.9, p.100321-100321, Article 100321

Toth, Peter P.

2022

Volltextzugriff (PDF)

1 – 25 von 1.581

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.226)
Mit Volltextzugriff
(1.364)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(990)
Life Sciences & Biomedicine
(849)
Humans
(511)
Male
(256)
Female
(240)
Cardiovascular System & Cardiology
(228)
Animals
(219)
Biological And Medical Sciences
(203)
Cardiac & Cardiovascular Systems
(193)
Risk Factors
(166)
Middle Aged
(162)
Pharmacology & Pharmacy
(162)
Medical Sciences
(136)
Biochemistry & Molecular Biology
(129)
Physical Sciences
(123)
Adult
(119)
Cholesterol
(119)
Cardiovascular Disease
(118)
Aged
(111)
Cardiovascular
(111)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association

Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile

Friedewald-Estimated Versus Directly Measured Low-Density Lipoprotein Cholesterol and Treatment Implications

Therapeutic Lipidology

Management of Statin Intolerance in 2018: Still More Questions Than Answers

Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis

Inflammation and cardiovascular disease: From mechanisms to therapeutics

Polyphenols: Potential Use in the Prevention and Treatment of Cardiovascular Diseases

2023: The year in cardiovascular disease - the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?

Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies

Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms

Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials

High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real-World Administrative Claims Analysis of Statin-Treated Patients With High Residual Cardiovascular Risk

Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study

Pooled Safety Analysis of Evolocumab in Over 6000 Patients From Double-Blind and Open-Label Extension Studies

Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation

Novel Therapeutic Targets for Managing Dyslipidemia

There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness

Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin‐associated muscle symptoms, under blinded and open‐label conditions

Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement

ASPC president's page: Getting back to basics one patient at a time

Use of supplemental long-chain omega-3 fatty acids and risk for cardiac death: An updated meta-analysis and review of research gaps

Lipoprotein Subfractions in Patients with Acute Coronary Syndromes: Should we Reach Beyond LDL-C?

The Relationship between COVID-19 and Hypothalamic–Pituitary–Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess—The CAPISCO International Expert Panel

President's page: ASPC is leading the way in preventive cardiology

Suchergebnisse filtern